Virus-Serum-Toxin Act and Regulations in 9 CFR Subchapter, Parts 101-124

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
Form APHIS Form 2070 Virus-Serum-Toxin Act and Regulations - Business	Form and Instruction	Modified	Available
Form APHIS Form 2080 Virus-Serum-Toxin Act and Regulations - Individual	Form	Modified	Available
Form APHIS Form 2080 Virus-Serum-Toxin Act and Regulations - State	Form	Modified	Available
0579-0013 (mergers) 2018 APHIS 79.pdf	Supplementary Document	Uploaded 2018-08-27	Available
0579-0013 (mergers) 2018 APHIS 71.pdf	Supplementary Document	Uploaded 2018-08-27	Available
0579-0013 (mergers) 2018 SS.pdf	Supporting Statement A	Uploaded 2018-08-27	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
231059	Virus-Serum-Toxin Act and Regulations - Foreign Gov't		New
2084	Virus-Serum-Toxin Act and Regulations - Business	Form and Instruction	Modified
200319	Virus-Serum-Toxin Act and Regulations - Individual	Form	Modified
183917	Virus-Serum-Toxin Act and Regulations - State	Form	Modified

ICR Details

OMB Control No: 0579-0013	ICR Reference No: 201804-0579-004
Status: Historical Active	Previous ICR Reference No: 201410-0579-002
Agency/Subagency: USDA/APHIS	Agency Tracking No:
Title: Virus-Serum-Toxin Act and Regulations in 9 CFR Subchapter, Parts 101-124
Type of Information Collection: Reinstatement with change of a previously approved collection	Common Form ICR:  No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 02/12/2019
	Date Received in OIRA: 09/25/2018
Terms of Clearance:

table that charts list comparision

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	02/28/2022	36 Months From Approved
Responses	298,820,801	0	0
Time Burden (Hours)	122,998	0	0
Cost Burden (Dollars)	0	0	0

---

Abstract: The purpose of this collection is to verify that compliance requirements for biological products used in the United States are met (i.e., the products are pure, safe, potent, and effective).

---

Authorizing Statute(s): US Code: 21 USC 151-159 Name of Law: VIRUS-SERUM-TOXIN ACT
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	83 FR 4024	01/29/2018
30-day Notice:	Federal Register Citation:	Citation Date:
	83 FR 47874	09/21/2018
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 4

table that charts list of burden

IC Title	Form No.	Form Name
Virus-Serum-Toxin Act and Regulations - Individual	APHIS Form 2080, APHIS Form 2081	Adverse Event Report ,   Adverse Event Report Follow-Up Information
Virus-Serum-Toxin Act and Regulations - Business	APHIS Form 2003, APHIS Form 2005, APHIS Form 2008, APHIS Form 2008A, APHIS Form 2047S, APHIS Form 2048, APHIS Form 2072, APHIS 2080, APHIS Form 2081, APHIS Form 2009, APHIS Form 2015, APHIS Form 2017, APHIS Form 2046S, APHIS Form 2070, APHIS Form 2071, APHIS Form 2001, APHIS Form 2007, APHIS Form 2018, APHIS Form 2020, APHIS Form 2046, APHIS Form 2047, APHIS Form 2049	Application for Authorization to Ship Master Seed or Cell Samples for Confirmatory Testing by APHIS ,   Application for Authorization to Ship Experimental Veterinary Biological Products ,   Application for Authorization to Ship Biological Product Samples for Confirmatory Testing by APHIS ,   Adverse Event Report ,   Adverse Event Report Follow-Up Information ,   Application for United States Veterinary Biologics Establishment License ,   Application for United States Veterinary Biological Product License ,   Application for United States Veterinary Biological Product Permit ,   Contact and Qualifications of Veterinary Biologics Personnel ,   Veterinary Biologics Production and Test Report ,   Continuation for Veterinary Biologics Production and Test Report ,   Center for Veterinary Biologics Inspection and Compliance Facility Document Submission Worksheet ,   Transmittal of Labeling or Outlines ,   Official Export Certificate for Animal Biological Products ,   Request for Reference, Reagent, or Reagent Seed Material ,   Shipment and Receipt of Biologics Samples ,   Certificate of Licensing and Inspection (Unrestricted) ,   Certificate of Licensing and Inspection (Unrestricted) (Spanish) ,   Certificate of Licensing and Inspection (Restricted) ,   Certificate of Licensing and Inspection (Restricted) (Spanish) ,   Center for Veterinary Biologics Inspection and Compliance E-Submission Form ,   Veterinary Biologics Regulatory E-Submission Form Policy, Evaluation, and Licensing
Virus-Serum-Toxin Act and Regulations - State	APHIS Form 2080, APHIS Form 2081	Adverse Event Report ,   Adverse Event Report Follow-Up Information
Virus-Serum-Toxin Act and Regulations - Foreign Gov't

---

ICR Summary of Burden

table that charts list of burden

	Total Approved	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	298,820,801	0	0	298,820,801	0	0
Annual Time Burden (Hours)	122,998	0	0	122,998	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: This request for reinstatement of a previously approved information collection with changes adds two new activities--a form with 1 hour of burden, and labeling with 8,365 hours of burden. Three existing activities had their response times adjusted, adding 4,339 hours of burden. This request also includes the merging in of activities and burden for 0579-0209 and 0579-0460. 0579-0209 adds one activity and 31,998 hours of burden, and 0579-0460 added two activities and 80 hours of burden.

---

Annual Cost to Federal Government: $1,932,946

Does this IC contain surveys, censuses, or employ statistical methods? No

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 09/25/2018

---